Acceleron Pharma
XLRN
#1586
Rank
โ‚ฌ10.19 B
Marketcap
166,63ย โ‚ฌ
Share price
0.00%
Change (1 day)
15,030.45%
Change (1 year)

Revenue for Acceleron Pharma (XLRN)

Revenue in 2021 (TTM): โ‚ฌ95.1 Million

According to Acceleron Pharma's latest financial reports the company's current revenue is โ‚ฌ0.10 Billion. In 2020 the company made a revenue of โ‚ฌ86.25 Million an increase over the revenue in the year 2019 that were of โ‚ฌ68.97 Million. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Acceleron Pharma from 2012 to 2021

Annual revenue

Year Revenue Change
2021 (TTM)โ‚ฌ95.1 M10.26%
2020โ‚ฌ86.25 M25.05%
2019โ‚ฌ68.97 M428.85%
2018โ‚ฌ13.04 M3.78%
2017โ‚ฌ12.56 M-51.45%
2016โ‚ฌ25.88 M53.47%
2015โ‚ฌ16.86 M23.68%
2014โ‚ฌ13.63 M-74.43%
2013โ‚ฌ53.34 M275.17%
2012โ‚ฌ14.21 M

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
โ‚ฌ30.32 B 28,751.41%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚ฌ12.90 B 12,179.72%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚ฌ81.75 B 77,669.50%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚ฌ0.21 M-99.80%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚ฌ11.44 M-89.11%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚ฌ51.17 M-51.31%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚ฌ51.86 B 49,243.76%๐Ÿ‡บ๐Ÿ‡ธ USA